53577-81-4 Usage
Uses
Used in Organic Synthesis:
Methyl 2-O,3-O,4-O-triacetyl-6-deoxy-β-D-xylo-5-hexenopyranoside is used as a building block in organic synthesis for the creation of various compounds. Its unique structure and functional groups make it a valuable component in the synthesis process.
Used in Biochemical Research:
In biochemical research, Methyl 2-O,3-O,4-O-triacetyl-6-deoxy-β-D-xylo-5-hexenopyranoside serves as a useful compound for studying the interactions and properties of different biomolecules. Its acetylated form contributes to its stability and resistance to degradation, making it suitable for research applications.
Used in Pharmaceutical Industry:
Methyl 2-O,3-O,4-O-triacetyl-6-deoxy-β-D-xylo-5-hexenopyranoside is used as a starting material or intermediate in the development of pharmaceutical compounds. Its potential applications in this industry can be attributed to its unique structure and functional groups.
Used in Agrochemical Industry:
Similarly, in the agrochemical industry, Methyl 2-O,3-O,4-O-triacetyl-6-deoxy-β-D-xylo-5-hexenopyranoside is utilized for the synthesis of various agrochemicals. Its properties make it a promising candidate for the development of new products in this field.
Check Digit Verification of cas no
The CAS Registry Mumber 53577-81-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,5,7 and 7 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 53577-81:
(7*5)+(6*3)+(5*5)+(4*7)+(3*7)+(2*8)+(1*1)=144
144 % 10 = 4
So 53577-81-4 is a valid CAS Registry Number.
53577-81-4Relevant academic research and scientific papers
TARGETED PEPTIDE CONJUGATES
-
Paragraph 0154, (2018/08/12)
The present invention relates to the preparation and use of therapeutic compounds for the treatment of diseases at specific subcellular target areas such as specific cellular organelles. In particular, the therapeutic compounds of the invention are specific for modifying enzyme activity within targeted organelles or structures of cells and tissues. Subcellular organelles and structures that may be specifically targeted by compounds of the present invention include lysosomes, autophagasomes, the endoplasmic reticulum, the Golgi complex, peroxisomes, the nucleus, membranes and the mitochondria.
An expeditious synthesis of iminosugars
Gandy, Michael N.,Piggott, Matthew J.,Stubbs, Keith A.
experimental part, p. 1409 - 1412 (2011/05/14)
A short and expedient synthesis of the potent glycosidase inhibitors, 1-deoxynojirimycin, miglitol, miglustat, 1-deoxymannojirimycin, and 1-deoxygalactonojirimycin is presented.
The fluorination (at C5) of some derivatives of D-glucose
Skelton, Brian W.,Stick, Robert V.,Stubbs, Keith A.,Watts, Andrew G.,White, Allan H.
, p. 345 - 353 (2007/10/03)
The photobromination of various per-esters of β-D-glucopyranose and α- and β-D-glucopyranosyl fluoride has yielded 5-bromo derivatives capable of conversion into the corresponding 5-fluorides. The best reagent for this conversion was found to be silver te
